<DOC>
	<DOCNO>NCT02721654</DOCNO>
	<brief_summary>The aim PLUS conduct multi-centre , blind , randomise , control trial ( RCT ) determine whether fluid resuscitation therapy `` balanced '' crystalloid solution ( Plasma-Lyte 148® ) decrease 90-day mortality critically ill patient require fluid resuscitation compare treatment use 0.9 % sodium chloride ( saline )</brief_summary>
	<brief_title>Plasma-Lyte 148® versUs Saline Study</brief_title>
	<detailed_description>Fluid resuscitation fundamental component management acutely critically ill patient choice fluid longstanding issue debate . Worldwide , 0.9 % saline traditionally widely use resuscitation fluid , however use increasingly challenge emerge evidence suggest high chloride content may clinically important adverse effect resuscitation so-called `` balance '' `` buffer '' crystalloids ( Plasma-Lyte 148® ) offer patient well outcomes . Given limitation current evidence , scientific , ethical health economic imperative provide accurate reliable estimate comparative risk versus benefit Plasma-Lyte 148® versus 0.9 % saline . The PLUS study prospective , multi-centre , parallel group , conceal , blind , randomise , control trial . The study test hypothesis heterogeneous population critically ill adult , random assignment Plasma-Lyte 148® intravascular volume resuscitation crystalloid fluid therapy Intensive Care Unit ( ICU ) result different 90-day all-cause mortality compare random assignment 0.9 % sodium chloride ( saline ) treatment . Each patient meet inclusion criterion exclusion criterion randomise receive either Plasma-Lyte 148® 0.9 % saline resuscitation episode compatible crystalloid therapy ICU 90 day randomisation . Other crystalloid fluid may use carrier fluid infusion drug either Plasma-Lyte 148® 0.9 % saline consider incompatible.The study treatment supply identical 1000 ml bag treatment assignment conceal . The volume study fluid administer titrated clinical endpoint determine treat clinician review clinically appropriate period resuscitation ICU treatment .</detailed_description>
	<mesh_term>Hypovolemia</mesh_term>
	<mesh_term>Plasma-lyte 148</mesh_term>
	<criteria>The patient receive fluid resuscitation define least 500mls least 5ml/kg patient weigh &lt; 100kg , administer one hour less increase maintain intravascular volume addition maintenance fluid , specific fluid use replace nonphysiological fluid loss The patient expect remain ICU beyond calendar day follow day enrolment expect well enough eating day follow enrolment An arterial central venous catheter situ , placement imminent part routine management Both PlasmaLyte 148® 0.9 % saline consider equally appropriate patient The requirement fluid resuscitation support least one seven prespecified clinical sign : heart rate &gt; 90 beat per minute ; systolic blood pressure &lt; 100 mmHg mean arterial pressure &lt; 75 mmHg ; central venous pressure &lt; 10 mmHg ; pulmonary artery wedge pressure &lt; 12 mmHg ; capillary refill time &gt; 1 second ; OR urine output &lt; 0.5 ml/kg least one hour Age le 18 year Patients previously receive fluid resuscitation ( define ) prescribe ICU current ICU admission Patients transfer directly another ICU receive fluid resuscitation ( define ) ICU admission Contraindication either study fluid e.g . previous allergic reaction PlasmaLyte 148® Patients admit ICU specific fluid requirement : treatment burn ; follow liver transplantation surgery ; correction specific electrolyte abnormality Patients traumatic brain injury consider risk develop cerebral oedema Patients death deem imminent inevitable Patients underlying disease process life expectancy &lt; 90 day Patients unlikely primary outcome ascertain Patients previously enrol PLUS</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Plasma-Lyte</keyword>
	<keyword>Sodium chloride</keyword>
	<keyword>Saline</keyword>
	<keyword>Fluid resuscitation</keyword>
	<keyword>Intravenous fluid therapy</keyword>
	<keyword>Critically ill</keyword>
	<keyword>Critical care</keyword>
</DOC>